13F Portfolios

SurgoCap Partners LP — NU HOLDINGS LTD NU: Quarterly 13F Position History

SurgoCap Partners LP has reported NU HOLDINGS LTD (NU) on 10 13F-HR filings in Pactolio's tracked window, first appearing in Q4 2023. As of Q1 2026, the position is sized at 9,866,060 shares ($141.8M market value, 4.73% of the equity book). Quarter-over-quarter share count change: 654,335 (-6.2%) .

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 10 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 9,866,060 654,335 -6.2% $141.8M 4.73% $14.37
Q4 2025 10,520,395 3,485,034 -24.9% $176.1M 4.88% $16.74
Q3 2025 14,005,429 +1,789,829 +14.7% $224.2M 6.36% $16.01
Q2 2025 12,215,600 +6,513,813 +114.2% $167.6M 6.42% $13.72
Q1 2025 5,701,787 1,449,765 -20.3% $58.4M 2.88% $10.24
Q4 2024 7,151,552 +147,375 +2.1% $74.1M 4.29% $10.36
Q3 2024 7,004,177 576,087 -7.6% $95.6M 5.10% $13.65
Q2 2024 7,580,264 +760,371 +11.1% $97.7M 5.72% $12.89
Q1 2024 6,819,893 3,130,815 -31.5% $81.4M 4.37% $11.93
Q4 2023 9,950,708 $82.9M 5.86% $8.33

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did SurgoCap Partners LP first disclose a NU position in 13F-HR filings?

SurgoCap Partners LP first reported NU HOLDINGS LTD (NU) on its 13F-HR filing for the period ending 2023-12-31 (Q4 2023). The position has appeared on 10 reported quarters within Pactolio's tracked window.

What was SurgoCap Partners LP's most recent quarter-over-quarter share-count change in NU?

Between Q4 2025 and Q1 2026, SurgoCap Partners LP reduced its NU position by 654,335 shares (-6.2%), leaving 9,866,060 shares at a market value of $141.8M.

Does the implied price-per-share represent SurgoCap Partners LP's cost basis in NU?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.